SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-274778"
 

Search: onr:"swepub:oai:DiVA.org:uu-274778" > Consensus on biomar...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Consensus on biomarkers for neuroendocrine tumour disease

Öberg, Kjell (author)
Uppsala universitet,Institutionen för medicinska vetenskaper
Modlin, Irvin M. (author)
Yale Univ, Sch Med, New Haven, CT 06510 USA.
De Herder, Wouter (author)
Erasmus MC, Endocrinol Sect, Dept Internal Med, Rotterdam, Netherlands.
show more...
Pavel, Marianne (author)
Charite, D-13353 Berlin, Germany.
Klimstra, David (author)
Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA.
Frilling, Andrea (author)
Univ London Imperial Coll Sci Technol & Med, London, England.
Metz, David C. (author)
Univ Penn Hlth Syst, Div Gastroenterol, Philadelphia, PA USA.
Heaney, Anthony (author)
Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.
Kwekkeboom, Dik (author)
Erasmus MC, Dept Nucl Med, Rotterdam, Netherlands.
Strosberg, Jonathan (author)
H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA.
Meyer, Timothy (author)
UCL, Inst Canc, London, England.
Moss, Steven F. (author)
Brown Univ, Liver Res Ctr, Providence, RI 02912 USA.
Washington, Kay (author)
Vanderbilt Univ, Dept Pathol, Med Ctr, Nashville, TN 37235 USA.
Wolin, Edward (author)
Univ Kentucky, Markey Canc Ctr, Lexington, KY USA.
Liu, Eric (author)
Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37235 USA.
Goldenring, James (author)
Vanderbilt Univ, Dept Cell & Dev Biol, Med Ctr, Nashville, TN 37235 USA.
show less...
 (creator_code:org_t)
2015
2015
English.
In: The Lancet Oncology. - 1470-2045 .- 1474-5488. ; 16:9, s. E435-E446
Related links:
https://urn.kb.se/re...
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • Management of neuroendocrine neoplasia represents a clinical challenge because of its late presentation, lack of treatment options, and limitations in present imaging modalities and biomarkers to guide management. Monoanalyte biomarkers have poor sensitivity, specificity, and predictive ability. A National Cancer Institute summit, held in 2007, on neuroendocrine tumours noted biomarker limitations to be a crucial unmet need in the management of neuroendocrine tumours. A multinational consensus meeting of multidisciplinary experts in neuroendocrine tumours assessed the use of current biomarkers and defined the perquisites for novel biomarkers via the Delphi method. Consensus (at > 75%) was achieved for 88 (82%) of 107 assessment questions. The panel concluded that circulating multianalyte biomarkers provide the highest sensitivity and specifi city necessary for minimum disease detection and that this type of biomarker had sufficient information to predict treatment effectiveness and prognosis. The panel also concluded that no monoanalyte biomarker of neuroendocrine tumours has yet fulfilled these criteria and there is insufficient information to support the clinical use of miRNA or circulating tumour cells as useful prognostic markers for this disease. The panel considered that trials measuring multianalytes (eg, neuroendocrine gene transcripts) should also identify how such information can optimise the management of patients with neuroendocrine tumours.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Publication and Content Type

ref (subject category)
for (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view